Tell us your experience of changing from Lamictal to Logem

From 01 Oct 2019, Pharmac only funds the generic brand of Lamotrigine, Logem. They no longer fund the Lamictal and Arrow brands.

To find out how the brand change affects people with epilepsy, Epilepsy New Zealand is creating a register of their experiences. Fill in this questionnaire to share your story with us.

If Logem affects you negatively, report your adverse event to Medsafe.

Who this is for

We’d like to hear from anyone with epilepsy who is changing, or has changed, from Lamictal to Logem. It doesn’t matter if you changed recently or some time ago.

If your child is changing brands, you’re welcome to fill it in on their behalf.

How we’ll use your information

We will save all survey data in a register, so we know how the brand change affects people with epilepsy. If you would like to give us your contact details, we’ll contact you again in three months to see how you’re getting on.

We will only publish the whole group’s responses, not individual responses. We won’t publish or forward your personal details to anyone. 

Who to contact if you have questions

If you have questions, please contact either:

  • your local educator at 0800 EPILEPSY (0800 37 45 37)
  • our national office at

Prev   Next 

Latest Updates

  • Covid 19 and Epilepsy Update 26 March 2020
    26 March 2020

    Epilepsy New Zealand has been receiving regular information from the Ministry of Health and other agencies, often more than once a day, showing just how quickly the situation is evolving. No doubt there will be many people, including those with epilepsy, who have questions around their risk and what to do in these uncertain times. Hopefully the information below may help reassure you and where necessary, prompt you to contact your trusted health professional.

  • BPAC issues new guidelines for Lamotrigine
    26 September 2019

    BPAC issues new guidelines for Lamotrigine.

  • Petition against Pharmac's drug changes
    29 August 2019

    A petition is underway calling on Pharmac to reverse its decision on Lamotrigine.

  • Epilepsy NZ Position Statement - Lamotrigine
    28 August 2019

    We opposed this change from Lamictal to Logem from the start, and staff have advocated on behalf of people with epilepsy in discussions with Pharmac.

  • Don't Give Up by Adele Hauwai
    4 December 2017

    Adele Hauwai has shared her Living With Epilepsy story as part of the Epilepsy NZ Tell Us About It Competition. People were asked to send in their stories about epilepsy, the challenges they faced and the lessons they have learned that they would like to share with the world.

  • New ILAE Seizure Classification
    10 March 2017

    The ILAE announces the publication in Epilepsia of two new landmark classification documents, one of seizure types and one of the epilepsies.

Show Your Support

Shop Online

Epilepsy NZ has an online shop!


Donate Today